Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail. Van Schependom J, Gielen J, Laton J, Nagels G Mult Scler. 2015 Jul 21. PMID: 26199353. Abstract CommentRecommendBookmarkWatch